Six brokerages set a USD 4.75 consensus for Clover Health stock

Published on 10/17/2026 at 21:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due on November 4, 2026. Clover Health stock stood at USD 4.48 on October 16, 2026, down 4.27 percent versus the Nasdaq prior close.

Analyst target and results date

Six brokerages supported a USD 4.75 average 12-month target on October 13, 2026.
Clover Health is scheduled to report third-quarter 2026 results on November 4, 2026.
Clover Health stock was last at USD 4.48 at 4:00 p.m. ET on October 16, 2026, down 4.27 percent versus the Nasdaq prior close.
The company had a USD 2.4 billion market capitalization and a USD 1.58 to USD 5.59 52-week range on October 16, 2026.

CLOV, US18914F1030, Illustration mit AI erstellt.

Six brokerages supported a USD 4.75 average 12-month target for Clover Health on October 13, 2026, according to MarketBeat. Against the last Nasdaq quote of USD 4.48, that target is 6.03 percent higher. Clover Health stock was last at USD 4.48 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 4.27 percent versus the Nasdaq prior close of USD 4.68.

Results date sets the next checkpoint

Clover Health will release its third-quarter 2026 financial results after the market closes on November 4, 2026, with a conference call scheduled for 5:00 p.m. ET. The date comes from the company release published October 7, 2026, which also identifies the business as a Nasdaq-listed physician enablement technology company. Clover Health describes its Clover Assistant platform as a tool for supporting clinical decisions and improving outcomes.

Stock sits below the yearly high

The USD 4.48 quote stood 19.86 percent below the USD 5.59 52-week high and 183.54 percent above the USD 1.58 low on October 16, 2026. Trading volume was 3,646,534 shares, compared with an average volume of 4,246,550 shares for the same market-data snapshot.

Valuation and market size

Clover Health had a USD 2.4 billion market capitalization on October 16, 2026. Its next scheduled reporting date is November 4, 2026, giving investors a defined date for the next company-specific update.

Comparison with peers

CLOV (Nasdaq, USD): minus 4.27 percent, market capitalization USD 2.4 billion
Oscar Health (NYSE, USD): minus 4.72 percent, P/E 22.78, market capitalization USD 8.3 billion
Alignment Healthcare (Nasdaq, USD): plus 1.60 percent, P/E 44.37, market capitalization USD 1.7 billion

Price remains the market frame

The stock ended the October 16 session below its 52-week high, while the average analyst target cited by MarketBeat stood above the latest Nasdaq quote. The next company date is November 4, 2026, when Clover Health is due to discuss third-quarter performance.

The last Nasdaq quote was USD 4.48 on October 16, 2026 at 4:00 p.m. ET, down 4.27 percent versus the Nasdaq prior close. The further course of trading is shown by the continuously updated real-time quote of Clover Health stock.